The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer.

Cui G, Shao M, Gu X, Guo H, Zhang S, Lu J, Ma H

DOI: 10.1080/21691401.2019.1620250
Published: 2019 Dec
Container: Artificial cells, nanomedicine, and biotechnology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2019.1620250,
  title = {The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer.},
  author = {Cui G and Shao M and Gu X and Guo H and Zhang S and Lu J and Ma H},
  year = {2019},
  journal = {Artificial cells, nanomedicine, and biotechnology},
  doi = {10.1080/21691401.2019.1620250},
  url = {https://doi.org/10.1080/21691401.2019.1620250}
}

RIS

TY  - JOUR
TI  - The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer.
AU  - Cui G
AU  - Shao M
AU  - Gu X
AU  - Guo H
AU  - Zhang S
AU  - Lu J
AU  - Ma H
PY  - 2019
JO  - Artificial cells, nanomedicine, and biotechnology
DO  - 10.1080/21691401.2019.1620250
UR  - https://doi.org/10.1080/21691401.2019.1620250
ER  -

APA

G, C., M, S., X, G., H, G., S, Z., J, L., & H, M. (2019). The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2019.1620250

Source records

pubmed · retrieved 2026-09-26T03:56:26.451Z